Novavax, sold under the brand name Nuvaxovid, is a protein-based COVID-19 vaccine — the same technology used to develop many other common vaccines, including those for influenza and shingles.

The fifth Covid-19 vaccine candidate has made its way into late-stage clinical trials in Western countries. Elizabeth Warren tells Elon Musk she's 'happy' to work with him on DOGE's goals to slash ...

Novavax has been gearing up to launch a phase 3 trial of what may result in an important product: A combined flu and coronavirus vaccine. But the company now faces a roadblock, saying regulators put a ...

Novavax Inc. said Thursday that its COVID-19 vaccine appears 89% effective based on early findings from a British study and that it also seems to work — though not as well — against new mutated ...

The new COVID-19 vaccine rolled out across the country last month, giving people access to the most recent versions of the Moderna, Pfizer, and Novavax shots. But, given that you have options, which ...

Vaccine maker Novavax says its shot is highly effective against COVID-19 and also protects against variants. The Maryland-based company on Monday announced results from a large, late-stage study in ...

Novavax has seen a surge in stock price due to recent COVID-19 and bird flu vaccine developments, reaching over $27 per share. The company is making headlines with updates on their COVID-19 vaccine, ...

WASHINGTON (Reuters) - A new kind of influenza vaccine works against the new swine flu virus in animals, Novavax Inc reported on Tuesday. The company said it made the vaccine, which uses so-called ...

In early pandemic days, Novavax (NASDAQ: NVAX) shares soared as investors bet on the company's ability to bring a coronavirus vaccine to market. But as the biotech fell behind in the race and ...